These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 32709718)

  • 21. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics Act with vB_AbaP_AGC01 Phage against
    Grygorcewicz B; Roszak M; Golec P; Śleboda-Taront D; Łubowska N; Górska M; Jursa-Kulesza J; Rakoczy R; Wojciuk B; Dołęgowska B
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).
    Huang G; Shen X; Gong Y; Dong Z; Zhao X; Shen W; Wang J; Hu F; Peng Y
    BMC Infect Dis; 2014 Dec; 14():681. PubMed ID: 25495514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performances of the Rapid Polymyxin
    Lescat M; Poirel L; Jayol A; Nordmann P
    Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
    [No Abstract]   [Full Text] [Related]  

  • 25. Sequential treatment effects on phage-antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii.
    Mukhopadhyay S; Zhang P; To KKW; Liu Y; Bai C; Leung SSY
    Int J Antimicrob Agents; 2023 Nov; 62(5):106951. PubMed ID: 37574030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of a lytic bacteriophage against extensively drug-resistant Acinetobacter baumannii infections and its dramatic effect in rat model of burn infection.
    Ghaznavi-Rad E; Komijani M; Moradabadi A; Rezaei M; Shaykh-Baygloo N
    J Clin Lab Anal; 2022 Jul; 36(7):e24497. PubMed ID: 35708005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
    Somily AM; Absar MM; Arshad MZ; Al Aska AI; Shakoor ZA; Fatani AJ; Siddiqui YM; Murray TS
    Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of phage-antibiotic combination strategy on multidrug-resistant Acinetobacter baumannii biofilms.
    Erol HB; Kaskatepe B; Yildiz S; Altanlar N
    J Microbiol Methods; 2023 Jul; 210():106752. PubMed ID: 37268109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.
    Liu B; Liu Y; Di X; Zhang X; Wang R; Bai Y; Wang J
    Rev Soc Bras Med Trop; 2014 Jul; 47(4):451-6. PubMed ID: 25229285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.
    Nordqvist H; Nilsson LE; Claesson C
    Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1845-1850. PubMed ID: 27510182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
    Moffatt JH; Harper M; Harrison P; Hale JD; Vinogradov E; Seemann T; Henry R; Crane B; St Michael F; Cox AD; Adler B; Nation RL; Li J; Boyce JD
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4971-7. PubMed ID: 20855724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group.
    Conlon JM; Sonnevend A; Pál T; Vila-Farrés X
    Int J Antimicrob Agents; 2012 Apr; 39(4):317-20. PubMed ID: 22326566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome characterization of the novel lytic phage vB_AbaAut_ChT04 and the antimicrobial activity of its lysin peptide against Acinetobacter baumannii isolates from different time periods.
    Leungtongkam U; Kitti T; Khongfak S; Thummeepak R; Tasanapak K; Wongwigkarn J; Khanthawong S; Belkhiri A; Ribeiro HG; Turner JS; Malik DJ; Sitthisak S
    Arch Virol; 2023 Sep; 168(9):238. PubMed ID: 37660314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
    Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
    Konai MM; Haldar J
    ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey.
    Ece G; Samlioglu P; Atalay S; Kose S
    Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Fri1-like Viruses Infecting Acinetobacter baumannii-vB_AbaP_AS11 and vB_AbaP_AS12-Characterization, Comparative Genomic Analysis, and Host-Recognition Strategy.
    Popova AV; Lavysh DG; Klimuk EI; Edelstein MV; Bogun AG; Shneider MM; Goncharov AE; Leonov SV; Severinov KV
    Viruses; 2017 Jul; 9(7):. PubMed ID: 28714913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.